John Maki
DIRECTOR
Clinical Sciences
3-D Matrix Medical technology
China
Biography
John Maki is President and CEO of Vicus Therapeutics, LLC. He was previously Managing Director of Technology Directors, Inc. and before Managing Director of the Audax Group. He has been a Principal at Bain Capital and a Consultant at Bain & Company. Mr. Maki has a A.B. from Harvard University. He currently serves on the boards of 3-D Matrix, of Addition Technology, an ophthalmic device company, and of Vicus Therapeutics. Mr. Maki also serves on the Board of Trustees of BIO NJ.John Maki is President and CEO of Vicus Therapeutics, LLC. He was previously Managing Director of Technology Directors, Inc. and before Managing Director of the Audax Group. He has been a Principal at Bain Capital and a Consultant at Bain & Company. Mr. Maki has a A.B. from Harvard University. He currently serves on the boards of 3-D Matrix, of Addition Technology, an ophthalmic device company, and of Vicus Therapeutics. Mr. Maki also serves on the Board of Trustees of BIO NJ.
Research Interest
Clinical data management, Clinical trails, Pharmacovigilance
